IRVINE, Calif., Sept. 1, 2016 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, is scheduled to
present at the 11th Annual Wells Fargo Healthcare Conference at the
Westin Boston Waterfront in Boston,
Massachusetts on Thursday, September
8, 2016.
Michael A. Mussallem, Edwards
Lifesciences' chief executive officer, is scheduled to speak to
conference attendees at 10:10 a.m.
PDT (1:10 p.m. EDT). A live
webcast of the company discussion will be available to all
interested parties on the Edwards Lifesciences investor relations
website at http://ir.edwards.com/events.cfm. Following the
discussion, an archived version of the webcast will be available on
the Edwards investor relations website in the News and Events
section, and via the Edwards Lifesciences Investor Relations App
for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of
heart valves and hemodynamic monitoring. Driven by a passion
to help patients, the company partners with clinicians to develop
innovative technologies in the areas of structural heart disease
and critical care monitoring that enable them to save and enhance
lives. Additional company information can be found at
www.edwards.com.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
Logo -
http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-11th-annual-wells-fargo-healthcare-conference-300319034.html
SOURCE Edwards Lifesciences Corporation